InsiderClue
Stocks · Technology · Laboratory Analytical Instruments

Cytek Biosciences, Inc.

CTKB Clue Score47
United States Fiscal year ends December CIK 0001831915
$5.43 +1.31% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $5.43 −74.87% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 23 Jul 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue92.8Operating income13.7Net income19.4EPS, diluted0.10Fiscal year 2021Revenue128.0 +37.8%Operating income9.2Net income3.0 −84.4%EPS, diluted0.00Fiscal year 2022Revenue164.0 +28.2%Operating income−1.8Net income2.5 −17.9%EPS, diluted0.02Fiscal year 2023Revenue193.0 +17.7%Operating income−27.8Net income−12.1 −589.0%EPS, diluted−0.09Fiscal year 2024Revenue200.5 +3.9%Operating income−20.5Net income−6.0EPS, diluted−0.05Fiscal year 2025Revenue201.5 +0.5%Operating income−40.4Net income−66.5EPS, diluted−0.52
FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 92.8 128.0 164.0 193.0 200.5 201.5
Growth +37.8% +28.2% +17.7% +3.9% +0.5%
Operating income 13.7 9.2 −1.8 −27.8 −20.5 −40.4
Net income 19.4 3.0 2.5 −12.1 −6.0 −66.5
Growth −84.4% −17.9% −589.0%
EPS, diluted 0.10 0.00 0.02 −0.09 −0.05 −0.52

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2020Gross margin55.7%Operating margin14.7%Net margin20.9%Free cash flow margin14.7%Fiscal year 2021Gross margin61.9%Operating margin7.2%Net margin2.4%Free cash flow margin0.2%Fiscal year 2022Gross margin61.6%Operating margin−1.1%Net margin1.5%Free cash flow margin−13.4%Fiscal year 2023Gross margin56.7%Operating margin−14.4%Net margin−6.3%Free cash flow margin0.3%Fiscal year 2024Gross margin55.4%Operating margin−10.2%Net margin−3.0%Free cash flow margin10.9%Fiscal year 2025Gross margin51.8%Operating margin−20.0%Net margin−33.0%Free cash flow margin−4.4%
FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 55.7% 61.9% 61.6% 56.7% 55.4% 51.8%
Operating margin 14.7% 7.2% −1.1% −14.4% −10.2% −20.0%
Net margin 20.9% 2.4% 1.5% −6.3% −3.0% −33.0%
Free cash flow margin 14.7% 0.2% −13.4% 0.3% 10.9% −4.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow15.2Capital expenditure−1.5Free cash flow13.6Fiscal year 2021Operating cash flow4.6Capital expenditure−4.4Free cash flow0.3 −98.0%Buybacks0.0Fiscal year 2022Operating cash flow−12.2Capital expenditure−9.7Free cash flow−22.0 −8,362.8%Buybacks0.0Fiscal year 2023Operating cash flow5.3Capital expenditure−4.6Free cash flow0.6Buybacks−44.2Fiscal year 2024Operating cash flow25.4Capital expenditure−3.5Free cash flow21.9 +3,352.4%Buybacks−21.6Fiscal year 2025Operating cash flow−4.7Capital expenditure−4.1Free cash flow−8.8 −140.1%Buybacks−15.1
FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 15.2 4.6 −12.2 5.3 25.4 −4.7
Capital expenditure −1.5 −4.4 −9.7 −4.6 −3.5 −4.1
Free cash flow 13.6 0.3 −22.0 0.6 21.9 −8.8
Growth −98.0% −8,362.8% +3,352.4% −140.1%
Buybacks n/a 0.0 0.0 −44.2 −21.6 −15.1

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2020Cash165.2Shareholders’ equity−16.0Fiscal year 2021Cash364.6Shareholders’ equity405.4Fiscal year 2022Cash296.6Shareholders’ equity425.5Fiscal year 2023Cash167.3Shareholders’ equity393.1Fiscal year 2024Cash98.7Shareholders’ equity395.7Fiscal year 2025Cash90.9Shareholders’ equity341.7
FY2020FY2021FY2022FY2023FY2024FY2025
Cash 165.2 364.6 296.6 167.3 98.7 90.9
Shareholders’ equity −16.0 405.4 425.5 393.1 395.7 341.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
92.8 128.0 164.0 193.0 200.5 201.5
Growth +37.8% +28.2% +17.7% +3.9% +0.5%
41.1 48.8 63.1 83.6 89.3 97.0
51.7 79.1 101.0 109.4 111.1 104.5
Growth +53.1% +27.6% +8.4% +1.5% −6.0%
13.7 24.4 34.9 44.2 39.4 36.5
9.4 20.8 34.7 44.0 43.1 58.9
13.7 9.2 −1.8 −27.8 −20.5 −40.4
Growth −33.0% −119.7%
14.4 5.9 1.3 −15.7 −5.7 −29.8
−5.0 2.9 −1.2 −3.6 0.3 36.7
19.4 3.0 2.5 −12.1 −6.0 −66.5
Growth −84.4% −17.9% −589.0%
Per share
0.11 0.00 0.02 −0.09 −0.05 −0.52
0.10 0.00 0.02 −0.09 −0.05 −0.52
Growth −100.0% −550.0%
29.1 76.7 134.5 135.3 130.6 127.7
32.6 81.5 138.6 135.3 130.6 127.7
Growth +150.1% +69.9% −2.4% −3.5% −2.2%

† The diluted share count jumps at 2021 and 2022, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 16.8% a year over five years.
  • Operating margin is down 34.8 points on five years ago, at -20.0%.
  • A net loss in 3 of 6 years on file.